Artiva Biotherapeutics（ARTV.US）股东结构 - 机构持仓、大股东与内部人士｜长桥证券

© 2026 Longbridge｜服务条款隐私政策

股东类型

风投/私募37.82%
机构投资者26.30%
公众及其他17.36%
上市公司12.27%
其他6.25%

主要股东

主要股东最新
股东
RA Capital Management, L.P.	37.82%	1,848.93 万	2.05%	+863.60 万	2026/07/31
GC Cell Corporation	12.27%	599.97 万	6.21%	+143.23 万	2026/05/11
Viking Global Investors LP	5.33%	260.42 万	--	+260.42 万	2026/05/11
5AM Venture Management, LLC	4.81%	235.33 万	4.71%	+0	2026/06/30
Franklin Resources, Inc.	4.09%	199.72 万	1.98%	+147.69 万	2026/06/30
VR Management, LLC	3.29%	160.96 万	3.33%	+0	2026/03/31
Vanguard Capital Management, LLC	2.31%	113.02 万	1.34%	+88.97 万	2026/06/30
CHI Advisors LLC	1.79%	87.45 万	--	+87.45 万	2026/06/30
Propel Bio Management, LLC	1.42%	69.64 万	0.93%	+57.33 万	2026/06/30
BlackRock, Inc.	1.42%	69.47 万	0.56%	+48.13 万	2026/06/30
venBio LLC	1.09%	53.13 万	1.58%	-11.72 万	2026/03/31
Silverarc Capital Management, LLC	1.07%	52.50 万	--	+52.50 万	2026/06/30
Geode Capital Management, LLC	0.72%	35.38 万	0.31%	+25.22 万	2026/06/30
Revelation Capital Management, LLC	0.61%	29.93 万	0.62%	+0	2026/03/31
Kvp Capital Advisors, LP	0.41%	20.00 万	--	+20.00 万	2026/06/30
Wellington Management Group LLP	0.40%	19.41 万	0.40%	+0	2026/03/31
UBS Asset Management AG	0.38%	18.40 万	0.37%	+18.25 万	2026/06/30
State Street Investment Management	0.34%	16.58 万	0.19%	+12.99 万	2026/06/30
Renaissance Technologies LLC	0.31%	15.10 万	0.01%	+7.10 万	2026/06/30
Heather RaymonSenior Vice President of Research & Early Development	0.30%	14.82 万	0.31%	-3,095.00	2026/05/19